Houston Texans Tackle Fan Safety with Evolv Technology
Gaining yardage in the NFL, Evolv now screens close to one million football fans every Sunday
WALTHAM, Mass.--(BUSINESS WIRE)-- Evolv Technology (NASDAQ: EVLV), the leader in AI-based weapons detection security screening, has added the Houston Texans to its growing roster of professional sports team customers. Beginning with the Texans’ first preseason game which took place in August, Evolv Express® is now screening fans who attend Texans home games.
Using AI and powerful sensor technology, Evolv Express accelerates physical security screening while being designed to maintain a high degree of weapons detection accuracy. For large capacity venues like NRG Stadium, this means getting to seats faster with less inconvenience.
“There’s a learning curve with any significant operational change, but one of the reasons that we chose to work with Evolv is how the technology can help expedite the ingress process so fans can get to their seats quickly,” said Juan Rodriguez, Houston Texans senior vice president of operations and event management. “We’re confident that our experience with Evolv Express will mirror that of other NFL franchises where the systems have had a prompt positive impact, and we’re proud to represent the expansion of Evolv’s presence in our community.”
It was announced this past spring that fellow Houston team the Astros implemented Express at Minute Maid Park ahead of its 2023 season. Within the NFL specifically, the Texans are the 12th franchise to partner with Evolv. Deployments with other NFL partners include the Pittsburgh Steelers, SoFi Stadium, home of the Los Angeles Chargers and LA Raiders, and Gillette Stadium (New England Patriots). The Tennessee Titans, now in their third season using Express, doubled fan ingress satisfaction scores after its installation.
“Express has proven to provide an enhanced overall street-to-seat experience for sports venues all over the country,” added John Baier, Evolv’s vice president of sports. “We’re excited to see how our deployment with the Texans translates to operational excellence and delighted fans.”
Evolv now works with more than 40 professional teams across the NFL, MLB, NHL, and MLS. The company is on pace to screen over 1 billion people by the end of the year.
About Evolv Technology
Evolv Technology (NASDAQ: EVLV) is transforming human security to make a safer, faster, and better experience for the world’s most iconic venues and companies as well as schools, hospitals, and public spaces, using industry leading artificial intelligence (AI)-powered weapons detection and analytics. Its mission is to transform security to create a safer world to work, learn, and play. Evolv has digitally transformed the gateways in places where people gather by enabling seamless integration combined with powerful analytics and insights. Evolv’s advanced systems have scanned more than 750 million people, second only to the Department of Homeland Security’s Transportation Security Administration (TSA) in the United States. Evolv has been awarded the U.S. Department of Homeland Security (DHS) SAFETY Act Designation as a Qualified Anti-Terrorism Technology (QATT) as well as the Security Industry Association (SIA) New Products and Solutions (NPS) Award in the Law Enforcement/Public Safety/Guarding Systems category. Evolv Technology®, Evolv Express®, Evolv Insights®, Evolv Cortex AI®, and Evolv Extend™ are registered trademarks or trademarks of Evolv Technologies, Inc. in the United States and other jurisdictions. For more information, visit https://evolvtechnology.com.
Forward-looking Statements
Certain statements in this press release may constitute “forward-looking” statements and information, within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 that relate to our current expectations and views of future events. In some cases, these forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. These forward-looking statements are subject to risks, uncertainties and assumptions, some of which are beyond our control. In addition, these forward-looking statements reflect our current views with respect to future events or our Company’s performance and are not a guarantee of future performance. Actual outcomes may differ materially from the information contained in the forward-looking statements as a result of a number of factors, including, without limitation, the risk factors set forth in our Annual Report on Form 10-K for the year ended on December 31, 2022, that was filed with the SEC on March 24, 2023, as may be updated in other filings we make with the SEC, including our Quarterly Report on Form 10-Q for the quarter ended on June 30, 2023 that was filed with the SEC on August 10, 2023. These statements reflect management’s current expectations regarding future events and operating performance and speak only as of the date of this press release. You should not put undue reliance on any forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231026184711/en/
Media:
Alexandra Smith Ozerkis
aozerkis@evolvtechnology.com
Investors:
Brian Norris
bnorris@evolvtechnology.com
Source: Evolv Technology
Released October 26, 2023